We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-17.07%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$1.52B
AUM Growth
-$55.5M
Cap. Flow
+$168M
Cap. Flow %
11.04%
Top 10 Hldgs %
38.58%
Holding
149
New
11
Increased
70
Reduced
43
Closed
11

Top Buys

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$41.6M
2
ILMN icon
Illumina
ILMN
+$33.2M
3
TDOC icon
Teladoc Health
TDOC
+$29.8M
4
ISRG icon
Intuitive Surgical
ISRG
+$25.9M
5
ABT icon
Abbott
ABT
+$14.7M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$17.1M
2
KTWO
K2M Group Holdings, Inc
KTWO
+$15.1M
3
EW icon
Edwards Lifesciences
EW
+$14.5M
4
PACB icon
Pacific Biosciences
PACB
+$13.9M
5
LH icon
Labcorp
LH
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 88.15%
2 Industrials 0.99%
3 Technology 0.52%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
51
Gilead Sciences
GILD
$167B
$7.69M 0.51%
123,000
-14,500
-11% -$1.01M
BIIB icon
52
Biogen
BIIB
$30.4B
$7.6M 0.5%
25,250
-13,995
-36% -$4.47M
COO icon
53
Cooper Companies
COO
$14B
$7.54M 0.5%
118,476
+27,232
+30% +$1.76M
XENT
54
DELISTED
Intersect ENT, Inc
XENT
$6.69M 0.44%
237,444
+3,217
+1% +$94.2K
GMED icon
55
Globus Medical
GMED
$10.5B
$6.62M 0.44%
153,031
+1,780
+1% +$88.8K
OMCL icon
56
Omnicell
OMCL
$2.09B
$6.62M 0.44%
108,042
+3,392
+3% +$230K
IART icon
57
Integra LifeSciences
IART
$1.5B
$6.58M 0.43%
145,779
+4,159
+3% +$228K
MOH icon
58
Molina Healthcare
MOH
$11.7B
$6.44M 0.42%
55,384
+4,906
+10% +$643K
RMD icon
59
ResMed
RMD
$28.9B
$6.31M 0.41%
55,392
-37,800
-41% -$4.05M
QDEL icon
60
QuidelOrtho
QDEL
$1.19B
$6.1M 0.4%
+125,000
New +$7.46M
HMSY
61
DELISTED
HMS Holdings Corp.
HMSY
$6.1M 0.4%
216,817
-10,203
-4% -$330K
HCA icon
62
HCA Healthcare
HCA
$82.3B
$5.85M 0.38%
47,034
+10,146
+28% +$1.36M
IRTC icon
63
iRhythm Holdings
IRTC
$3.64B
$5.82M 0.38%
83,792
+14,131
+20% +$1.07M
REGN icon
64
Regeneron Pharmaceuticals
REGN
$70.9B
$5.68M 0.37%
15,200
-10,280
-40% -$3.76M
TRHC
65
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$5.6M 0.37%
87,857
+973
+1% +$68.9K
VTRS icon
66
Viatris
VTRS
$20.1B
$5.4M 0.35%
196,950
-368,400
-65% -$11.9M
QTRX icon
67
Quanterix
QTRX
$182M
$5.24M 0.34%
285,907
-27,323
-9% -$490K
TFX icon
68
Teleflex
TFX
$5.96B
$5.1M 0.34%
19,748
+1,956
+11% +$495K
QTNT
69
DELISTED
Quotient Limited Ordinary Shares
QTNT
$5.1M 0.34%
20,840
+2,794
+15% +$733K
IDXX icon
70
Idexx Laboratories
IDXX
$44.8B
$4.52M 0.3%
24,307
– –
MTLS
71
Materialise
MTLS
$379M
$4.31M 0.28%
215,192
+4,461
+2% +$64.9K
INGN icon
72
Inogen
INGN
$178M
$4.13M 0.27%
33,292
+10,031
+43% +$1.65M
XRAY icon
73
Dentsply Sirona
XRAY
$2.81B
$4.13M 0.27%
110,878
– –
GH icon
74
Guardant Health
GH
$20.7B
$4.1M 0.27%
+109,117
New +$4.02M
HSIC icon
75
Henry Schein
HSIC
$10B
$4.03M 0.27%
65,494
– –
1 2
3
4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q4 2018 Portfolio in Review

As of Q4 2018, Bellevue Group held 149 positions worth $1.52B, down 3.5% from $1.58B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Bellevue Group deployed $168M of net new capital in Q4 2018, opening 11 new positions and adding to 70 existing holdings. Its largest new stake was QuidelOrtho: 125,000 shares worth $6.1M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 93% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Centene, an estimated $17.1M trimmed.

  • Bellevue Group's largest Q4 2018 buy was QuidelOrtho: 125,000 shares worth $6.1M.
  • Bellevue Group added most to Align Technology in Q4 2018, an estimated $41.6M increase.
  • Bellevue Group's biggest Q4 2018 reduction was Centene, cutting an estimated $17.1M.
  • Bellevue Group fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $15.1M.
  • Bellevue Group's ten largest holdings make up 39% of its $1.52B portfolio in Q4 2018.
  • Bellevue Group opened 11 new positions and closed 11 in Q4 2018.
  • Bellevue Group's portfolio value fell 3.5% quarter-over-quarter to $1.52B.

Based on Bellevue Group's 13F filing for Q4 2018, filed 12 Feb 2019.